conferences.iaea.org will be undergoing maintenance between 16-18 of December 2019 to use Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.
International Symposium on Trends in Radiopharmaceuticals (ISTR-2019)

from Monday, 28 October 2019 (08:00) to Friday, 1 November 2019 (18:00)
Vienna International Centre

        : Sessions
    /     : Talks
        : Breaks
28 Oct 2019
29 Oct 2019
30 Oct 2019
31 Oct 2019
1 Nov 2019
AM
08:00
Registration (until 09:30) (Foyer)
09:30
OPENING CEREMONY (until 10:30) (M1)
10:30 --- Coffee Break ---
11:00
S.1 (until 12:30) (M1)
11:00 M. Venkatesh: Production of reactor based radioisotopes: An international portfolio (IS) - Meera Venkatesh   (M1)
11:25 R. Mikolajczak: Production and supply of medical radioisotopes: A Polish experience (IS)   (M1)
11:45 Selective separation of no carrier added 47Sc from reactor irradiated Ca using zirconium vanadate gel for nuclear medical applications (9) - Mohamed Gizawy (Lecturer at Radioisotopes Production Facility (RPF), Egyptian Second Research Reactor (ETRR-2), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt)   (M1)
12:00 Synthesis and neutron activation of Lu2O3 nanoparticles functionalized with target specific peptides - Ms Guillermina Ferro-Flores   (M1)
12:15 Towards a robust supply chain for medical radioisotopes - Mr Titus Tielens (PALLAS)   (M1)
09:00
S.4 (until 10:30) (M1)
09:00 J. Lewis: Development and application of monoclonal antibody based radiopharmaceuticals (IS)   (M1)
09:25 C. Decristoforo: Theranostic Radiopharmacy (IS)   (M1)
09:45 Innovative medical radioisotopes for theranostic application, and how they are produced - Mr Vadim Gadelshin (AG LARISSA, Institute of Physics, Johannes Gutenberg University Mainz (Germany))   (M1)
10:00 Preparation and Preclinical Evaluation of 64Cu-NOTA-anti MUC1 as a Radioimmunoconjugate for Diagnosis of MUC1+ breast cancer by PET - Dr Behrouz Alirezapour (Radiation Application Research School, Nuclear Science and Technology Research Institute, Tehran, IRAN)   (M1)
10:15 Development of a new prostate cancer theranostic radiopharmaceutical - Laura Melendez-Alafort (Veneto Institute of Oncology IOV-IRCCS)   (M1)
10:30 --- Coffee Break ---
11:00
S.5 (until 12:30) ()
11:00 A. Duatti: Revisting 99mTc Radiopharmaceuticals with recent advances in chemistry & imaging tools (IS)   (M1)
11:25 G. Ferro-Flores: Production of radiolabelled peptides for SPECT-based theranostics (IS)   (M1)
11:45 Radiopharmacy and growth of nuclear medicine in developing countries - Prof. Salah Bouyoucef (Department of nuclear medicine ) Mrs Amel Fellah (Nuclear medicine department )   ()
12:00 Selective αvβ3 integrin detection using [99mTc(N)PNP43]-tagged RGDechi Peptides: synthesis and pharmacological studies - Cristina Bolzati (ICMATE-CNR)   ()
12:15 The past, present and future trends in radiopharmaceuticals production in Brazil - Mr Efrain Araujo Perini (Nuclear and Energy Research Institute (IPEN), Brazilian Nuclear Energy Commission (CNEN))   ()
09:00
Clinical advances in Nuclear Medicine (until 10:30) ()
09:00 D. Paez: IAEA activities related to Nuclear Medicine   ()
09:30 H. Macapinlac: Recent Advances in Nuclear Medicine: diagnostic and therapy   ()
10:00 D. Le: Production and Use of Cyclotron-produced Radiopharmaceuticals at MD Anderson Cancer Center   ()
09:00
S.7 (until 10:30) (M1)
09:00 P. Elsinga: Recent advances in the development of 18F and 11C radiopharmaceuticals (IS)   (M1)
09:25 C. Decristoforo: Recent advances in the development of 68Ga radiopharmaceuticals (IS)   (M1)
09:45 SYNTHESIS AND IN VITRO AND IN VIVO EVALUATION OF IODINE-124-LABELED PSMA PEPTIDES: POTENTIAL THERANOSTIC RADIOPHARMACEUTICALS FOR PROSTATE CANCER - Dr IBRAHIM ALJAMMAZ ( KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTRE )   (M1)
10:00 V. Kumar: A radiocopper somatostatin anolog (Cu-Sartate) for NET theranostics (IS)   (M1)
10:15 Comparative study of [18F]PSMA-1007and [68Ga]PSMA-11 for Prostate Cancer PET Imaging in Thailand - Ms Wisakha Chintawan (National Cyclotron and PET Centre, Chulabhorn Hospital, Chulabhorn Royal Academy)   (M1)
10:30 --- Coffee Break ---
11:00
S.8 (until 12:30) (M1)
09:00
S.11 (until 10:30) (M1)
09:00
Technical Cooperation Success Stories (until 10:30) ()
09:00 IAAEA TC Speakers   ()
09:30 R. Montaña: Sustainable production of 99mTc generators and radiopharmaceuticals an IAEA/Cuban experience (IS)   ()
09:55 Yelena Chakrova Kazhakstan   ()
10:15 A. Duran: Strengthening capacities for the development of radiotracers labelled with 18F, different from fluordesoxyglucose in the FCDN (N.6)   ()
10:30 --- Coffee Break ---
11:00
S.12 (until 12:30) ()
09:00
S.15 (until 10:30) (M1)
10:30 --- Coffee Break ---
11:00
WNU Olympiad (until 12:30) (M1)
PM
12:30 --- Lunch Break ---
14:00
S.2 (until 15:35) (M1)
14:00 S.M. Qaim: Accelerator based production of non-conventional positron emitters and therapeutic radionuclides (IS)   (M1)
14:25 S. Lapi: Production of radiometals using medical cyclotron (IS)   (M1)
14:45 A. Abrunhosa: Application and development of liquid targets for PET radiopharmacy (IS)   (M1)
15:05 J.Hoon Park: Radioisotope production and development with 30MeV cyclotron (IS)   (M1)
15:20 V. Radchenko: Production and application of 225Ac/213Bi: TRIUMF experience and perspectives (IS)   (M1)
15:30 --- Coffee Break ---
16:00
S.3 (until 17:30) (M1)
16:00 C. Cutler: Supply of 99Mo: Focus on US   (M1)
16:20 B. Zhujkov: Successes and problems in the development of radioisotope generators   (M1)
16:40 J. Harvey: Production of 99Mo: North Star projects   (M1)
17:00 J. Osso: Role of the IAEA on the supply of 99Mo   (M1)
17:15 Safeguards on the production of medical radioisotopes   (M1)
18:00 --- Welcome Reception ---
19:45 Test A - Vojna ngjeqari   ()
12:30 --- Lunch Break ---
12:45
Milabs Working Lunch (until 13:45) ()
14:00
Poster Session (until 15:30) (M02)
15:30 --- Coffee Break ---
16:00
S6. (until 17:30) (M1)
16:00 M.R.A. Pillai: Production and quality control of beta emitters bone pain paliation agents (IS)   (M1)
16:25 Comparison of promising new short range therapeutic radiopharmaceuticals using 225Ac, 213Bi and 161Tb - Prof. Zeevaart Jan Rijn (Necsa, Radiochemistry)   (M1)
16:45 FREEZE-DRIED KIT FOR QUICK AND EFFICIENT PREPARATION OF 188ReN-DEDC/LIPIODOL IN HOSPITAL RADIOPHARMACY - Mr Viju Chirayil (Bhabha Atomic Research Centre)   (M1)
17:00 Production of Theranostic 153Samarium-labelled Polystyrene Microspheres for Hepatic Radioembolization - Chai Hong Yeong (Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia)   (M1)
17:15 Radiolabeling and Pre-Clinical Evaluation of Y-90-DOTATATE - Formulated Using Y-90-Acetate from High Level Liquid Waste - Dr Avik Chakrabotry (Radiation Medicine Centre, BARC, Mumbai, India)   (M1)
18:00
Side Event (until 19:30) (M1 )
21:15 IN VIVO STUDY OF RADIOLABELED FLAVONOID 99mTc-QUERCETIN AS CANCER RADIOTRACER ON NORMAL BALB/C MICE - Mrs eva maRIA widyasari (batan)   ()
21:30 The critical parameters of Ga-68 labelling of POLATOM’s PSMA-11 kit. - Mr Michal Maurin (National Centre for Nuclear Research, Radioisotope Centre POLATOM)   ()
21:45 111In-labelled bifunctional agents for dual targeting of breast cancer cells - Dr Lurdes Gano (Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, )   ()
22:00 Radiopharmaceutical production of 68Ga-PSMA at the National Cancer Institute. Bogotá-Colombia. - Ms NIDIA ESPERANZA DELGADO LOPEZ (INSTITUTO NACIONAL DE CANCEROLOGIA)   ()
22:15 Synthesis and biodistribution of 1-((2-methoxyphenyl) piperazine)ferrocenecarboxamide labeled with technetium-99m as a potential brain receptor imaging ag - Dr Nadia Malek (CNSTN)   ()
22:30 Development and Evaluation of 18F-radiolabeled Acetaminophen (Paracetamol) for Tumour Imaging Based on COX-2 Overexpression - Mr SAIKAT NANDY (RMC,BARC,MUMBAI,INDIA)   ()
22:45 Study of the physicochemical stability of HMPAO-Technetium (99mTc) - Najla AYACHI (Ministère de la santé)   ()
23:00 Radiosynthesis of 1-{4-[4-(2-[18F] Fluoroethoxy)-phenyl] Piperazine-1-yl} ethenone and its evaluation in animal models bearing C57BL6 melanoma xenograft - Mr SOMNATH KAR (BARC)   ()
23:15 [99mTc(N)(DASD)(PNPn)]+ (DASD=1,4-dioxa-8-azaspiro[4,5]decandithiocarbamate, PNPn=bisphosphinoamine) for myocardial imaging. - Dr Bolzati Cristina (ICMATE-CNR)   ()
23:30 Synthesis and biodistribution study by rats of two new 99mTc-Tricarbonyl complexes as potential brain imaging agents - Prof. mouldi Saidi (cnstn)   ()
23:44 A practical method for the preparation of 18F[TFB] labeled with sodium fluoride, using a ITG IQS Fluidic Labelling Module - Dr Juan C Manrique Arias (Instituto Nacional de Cancerología) Ms Osvaldo García Pérez (Instituto Nacional de Cancerología)   ()
23:44 An automated synthesis method for Ga-68 labelled ubiquicidin 29-41 - Jannie Le Roux (Stellenbosch University)   ()
23:44 Bioconjugates of barium ferrite as a Ra-223 carriers in alpha-radioimmunotherapy - Weronika Gawęda (Institute of Nuclear Chemistry and Technology)   ()
23:44 CORRELATION BETWEEN THE YIELD OF PRODUCED [18F]FDG AND THE ACTIVITY RETAINED DURING SYNTHESIS - Katerina Kolevska   ()
23:44 Clinical indications and labelling procedures influencing in vitro stability and early myocardial uptake of 99mTc-tetrofosmin - Dr Amel Taïbi (Nuclear medicine department ) Salah Eddine Bouyoucef (Department of Nuclear Medicine CHU Bab El Oued, 16000 Algiers Algeria)   ()
23:44 Comparative Evaluation of Tc-99m Octreotide, Synthesized by Different Labeling Methods: For Diagnostic Accuracy Assessment in Neuro-endocrine Tumors - Mr Naseer Naseer Ahmed (Department of Nuclear Medicine, AECH-NORI)   ()
23:44 Comparison of 68Ga-NOTA-Bisphophonate with 99mTc-MDP in 34 patients with skeletal metastases in various type of cancers - Mr Raviteja Nanabala   ()
23:44 Complexes of copper and bismuth cations with acyclic and macrocyclic polyamines bearing picolinic pendant arms - Dr Bayirta Egorova (Lomonosov Moscow state university)   ()
23:44 Design, synthesis and evaluation of a family of 99mTc estradiol derivatives for breast cancer imaging - Ms Maria Emilia Tejeria (Área Radioquímica, Facultad de Química, Universidad de la República (UdelaR), Montevideo, Uruguay.)   ()
23:44 Development and evaluation of a 68Ga-labeled Angiotensin peptide coupled to Rhodamine for diagnostic imaging of heart. - Mr M Okarvi Subhani (King Faisal Specialist Hospital and Research Centre. Riyadh 11211, Saudi Arabia.)   ()
23:44 Development of Automatic System for Production of Small Batches of Radioiodine Capsules - Mr Aleksandar Vukadinovic (Vinca Instutute of Nuclear Sciences)   ()
23:44 Development, characterisation and in vivo evaluation of two 68Ga-labelled NPY analogues as potential tracers for breast cancer imaging. - María Elena Cardoso Moreno (Area de Radioquímica-Facultad de Química-Universidad de la República Oriental del Uruguay-UdelaR)   ()
23:44 Evaluating Quality Control 18F-FDG: Experience in Sultan Qaboos Unviversity Hospital, Oman - Ms Naima Tag   ()
23:44 Exploring Ga-68 Trastuzumab Fab for noninvasive PET imaging to detect HER2 expressing lesions. - Dr Jaya Shukla (Department of Nuclear Medicine)   ()
23:44 Formulation and Radiolabelling of Ethambutol with Technetium-99m for Detection of Extrapulmonary Tuberculosis - Ms Wening Lestari (Center for Radioisotope and Radiopharmaceutical Technology,National Nuclear Energy Agency)   ()
23:44 Freeze-dried kit formulation of 177Lu- and 90Y-labeled immunoconjugates of Trastuzumab – formulation and characterization - Prof. Emilija Janevik-Ivanovska (Faculty of Medical Sciences, Goce Delcev University Stip, Republic of Macedonia)   ()
23:44 Fully Automated Radiosynthesis of 18F-16-α-Fluoroestradiol ([18F]FES) With Solid Phase Extraction Cartridge Purification by Sep Pak® Plus ALOX N - Mr SAIKAT NANDY (RMC, BARC, MUMBAI, INDIA)   ()
23:44 Impact of hospital production vs commercial kits purchase of 68Ga-DOTA peptides. - Dr Julien Costes (Pharmacie, Centre Hospitalier Universitaire Vaudois)   ()
23:44 Improvement of synthesizing material and method for an in-house production of [18F]-florbetapir PET tracer for imaging beta amyloid deposition in the brain - TOSSAPORN SIRIPRAPA (Faculty of Medicine Siriraj Hospital)   ()
23:44 In house preparation and biodistribution of 64Cu-ATSM, 64Cu-PTSM and 64Cu-DOTATATE for theranostic application - Dr Thaer ASSAAD (AECS)   ()
23:44 In vitro NK1R affinity evaluation of novel radioconjugates based on peptide antagonist SPANTIDE I and Ga-68/Lu-177 theranostic-like isotopes for glioma cancer - Mr Paweł Halik (Institute of Nuclear Chemistry and Technology)   ()
23:44 Influence of 99mTc-chelation at N-terminal and/or C-terminal on receptor binding affinity of NGR peptides - Dr V Kusum Vats (Bhabha Atomic Research Centre)   ()
23:44 Influence of the source of Lu-177 on radiopharmacy waste management – an estimate - Sietske Rubow (Stellenbosch University)   ()
23:44 LABELLING OF ANTI-CD20 MONOCLONAL ANTIBODY CIMABior WITH 90Y. - Mr Madian Pino Peraza (Centro de Isótopos (CENTIS))   ()
23:44 Labeling of PSMA-11 with 68Ga in NaHCO3 - Ms Kamila Urbanová   ()
23:44 Membrane interacting peptides as positron emission tomography (PET) based infection imaging probes - Mrs JYOTSNA BHATT MITRA (BHABHA ATOMIC RESEARCH CENTRE)   ()
23:44 Methods of Integration of Radio Cu64 label in Luminescent Copper Nano clusters for Pre and Intra operative Imaging and Therapy of Pancreatic Cancer - Dr SONY GEORGE (HEAD, DEPARTMENT OF CHEMISTRY, UNIVERSITY OF KERALA)   ()
23:44 Nucleophilic synthesis of 6-[18F]fluoro-L-DOPA via copper mediated radiofluorination - Dr Raisa Krasikova (N.P. Bechtereva Institute of Human Brain, Russian Academy of Science)   ()
23:44 Nucleophilic synthesis of [18F]FDOPA by using an automated module : A summary of the results of 18 batches - Mr Raviteja Nanabala   ()
23:44 Optimization of the automatic synthesis of 16α-[18F]fluoroestradiol in the SYNTHRA RNplus Research Module - Ms Pía Pereira (Facultad de Química, UdelaR)   ()
23:44 Potential radiotracers based on the 4’-O-methylhonokiol structure for PET visualization of neuroinflammation - Dr Natalia Gomzina (N.P. Bechtereva Institute of Human Brain, Russian Academy of Science)   ()
23:44 Preclinical evaluation of the theranostic 68Ga/177Lu-[DOTA-CXCR4-L] pair - Dr Myrna Luna-Gutiérrez (INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES)   ()
23:44 Preparation of 177Lu-DOTA-Trastuzumab: an insight into the in-house optimized radiochemistry procedures employed for patient dose preparation - Dr Mohini Guleria (Bhabha Atomic Research Centre)   ()
23:44 Preparation of Single Patient Dose of Lu-177-DOTA-Rituximab – Using Low Specific Activity Lu-177-Chloride - Dr Avik Chakrabotry (Radiation Medicine Centre, BARC, Mumbai, India)   ()
23:44 Radiolabeled TATE functionalized Gold Nanoparticles for potential use in imaging and therapy of Neuroendocrine tumors - Mr Dheeraj Kumar (Board of Radiation and Isotope Technology)   ()
23:44 Radiolabeled peptidomimetic inhibitor of the VEGF/NRP-1 complex for the imaging of malignant tumours - preliminary research - Katarzyna Masłowska (Institute od Nuclear Chemistry and Technology)   ()
23:44 Recent advances in Ga-68 Radiopharmaceuticals and Ga-68 Bisphosphonates for the theranostic management of Neuroendocrine tumours. - Prof. VIJAY KUMAR (Westmead Hospital, The Children's Hospital at Westmead & Sydney Medical School, Sydney University)   ()
23:44 Synthesis and preclinical evaluation of 64Cu-NOTA-HYNIC-iPSMA - Dr Blanca Ocampo-García (Instituto Nacional de Investigaciones Nucleares)   ()
23:44 Synthesis of [18F]PSMA-1007 for Imaging Prostate Cancer by using an automated module and clinical studies - Mr Raviteja Nanabala   ()
23:44 Synthesis of m-Iodobenzylguanidine (m-IBG) by solid phase method and its evaluation - Mr ammar CHAREF   ()
23:44 Tc 99m octreotide in Neuroendocrine tumors: a different Radiotracer from traditional 111 In: Our experience. - Mariela Agolti (Centro Medicina Nuclear Clinica Modelo .Parana)   ()
23:44 Technetium 99m labeled Human immunoglobulin G polyclonal antibody – different approach for better results - Aschalew Alemu Marie (Addis Ababa University, College of Health Sciences, School of Medicine, Internal Medicine Department, Nuclear Medicine Unite)   ()
23:44 The synthesis and cytotoxicity of 64Cu/NOTA-terpyridine platinum conjugate, as a novel theranostic agent - Mr Meysam Khosravifarsani (Department of Nuclear Medicine and Radiobiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada)   ()
23:44 Total solid-phase synthesis of DOTA-Functionalized tumor targeting peptides for PET imaging and therapy - Mr M Okarvi Subhani (King Faisal Specialist Hospital and Research Centre. Riyadh 11211, Saudi Arabia.)   ()
23:44 Use of tetrabutylammonium tosylate in conjunction with chiral NiII complex precursor for automated synthesis of [18F]FET - Ms Olga Fedorova (N.P.Bechtereva Institute of Human Brain RAS)   ()
23:44 Utility of Gamma Camera as an Effective Non-Invasive Imaging Modality for Docetaxel loaded Liposomal Chitosan Nanoparticles: Synthesis and the In-Vivo trafficking in Animal Model. - Mr Naseer Naseer Ahmed (Department of Nuclear Medicine, Nuclear Medicine, Oncology and Radiotherapy Institute ) Dr Ayesha Ayesha Ammar (Department of Nuclear Medicine, Nuclear Medicine oncology and Radiotherapy Institute )   ()
23:44 [18F]-FPSMA1007 SYNTHESIS HPLC FREE ON FASTLAB PLATFORM QC EVOLUTION - Giancarlo Gorgoni (Sacro Cuore Hospital) Emiliano Cazzola (Sacro Cuore Hospital)   ()
23:44 [89Zr]ZrOx/Cl preparation based on commercial cassette base, synthesis module. - Emiliano Cazzola (Sacro Cuore Hospital)   ()
12:30 --- Lunch Break ---
14:00
S.9 (until 15:30) (M1)
15:30 --- Coffee Break ---
16:00
S.10 (until 17:30) (M1 )
18:00
Women in Radiopharmaceutical Sciences (until 19:00) ()
12:30 --- Lunch Break ---
14:00
Poster Session II (until 15:30) (M1 )
15:30 --- Coffee Break ---
16:00
S. 13 (until 17:30) (M1)
18:00
Side Event (until 19:00) (M1)
12:30 --- Lunch Break ---
14:00
Closing Session and Award Ceremony (until 15:30) (M1)
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×